Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABIGATRAN ETEXILATE vs DALBAVANCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DABIGATRAN ETEXILATE vs DALBAVANCIN: Safety Overview

Metric DABIGATRAN ETEXILATE DALBAVANCIN
Total FAERS Reports 37,091 1,107
Deaths Reported 5,806 54
Death Rate 15.7% 4.9%
Hospitalizations 21,235 288
Average Patient Age 74.4 yrs 61.0 yrs
% Female Patients 45.8% 46.7%
FDA Approval Date Aug 12, 2024 May 23, 2014
Manufacturer Apotex Corp. Fresenius Kabi USA, LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription